PTK2 and cancer: The mechanism for SIRT3 as a tumor promoter can be explained by the fact that SIRT3 might engage in cross-talk with Fas/receptor-interacting protein (RIP)/focal adhesion kinase (FAK) death–survival pathways in cancer cells [7].